Harmony Biosciences Holdings, Inc.HRMYNASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank43
3Y CAGR-35.1%
Studio
Year-over-Year Change

Price to free cash flow ratio

3Y CAGR
-35.1%/yr
Annual compound
Percentile
P43
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
20256.18-30.9%
20248.95+2.1%
20238.77-61.2%
202222.60-9.5%
202124.97+106.1%
2020-412.39-1222.6%
2019-31.18+31.3%
2018-45.40-